What is the equivalent medication to benazepril (Angiotensin-Converting Enzyme inhibitor) 20mg for a patient with hypertension (high blood pressure) and potential impaired renal function (kidney disease)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Equivalent Dosing to Benazepril 20mg

For a patient on benazepril 20mg, the equivalent ACE inhibitor doses are: lisinopril 20mg, enalapril 10mg, ramipril 10mg, or quinapril 20mg daily. 1

ACE Inhibitor Equivalents

The following ACE inhibitors provide comparable antihypertensive efficacy to benazepril 20mg once daily:

  • Lisinopril 20mg once daily - Direct equipotent dose 1
  • Enalapril 10mg once daily - Approximately equivalent antihypertensive effect 1, 2
  • Ramipril 10mg once daily - Comparable efficacy, particularly beneficial in CKD 1
  • Quinapril 20mg once daily - Similar potency and duration of action 1
  • Captopril 50mg twice daily - Requires twice-daily dosing due to shorter half-life 1

Special Considerations for Renal Impairment

In patients with impaired renal function (creatinine clearance <30 mL/min), benazepril dosing should be reduced to 5-10mg daily, and equivalent dose reductions apply to alternative ACE inhibitors. 3, 4

  • Mild-to-moderate renal impairment (CrCl >30 mL/min) requires no dose adjustment for benazepril 3
  • Severe renal impairment (CrCl <30 mL/min) necessitates starting at 5mg daily and titrating cautiously 3, 4
  • Benazepril has demonstrated renoprotective effects even in advanced chronic kidney disease (serum creatinine 3.1-5.0 mg/dL), reducing the risk of doubling serum creatinine, ESRD, or death by 43% compared to placebo 4

Alternative to ACE Inhibitors: ARBs

If ACE inhibitors are not tolerated (typically due to cough), angiotensin receptor blockers (ARBs) provide equivalent renoprotective and antihypertensive benefits. 1, 5

ARB equivalents to benazepril 20mg:

  • Losartan 100mg once daily 1
  • Valsartan 160mg once daily 1, 5
  • Irbesartan 300mg once daily 1
  • Candesartan 16-32mg once daily 1

Critical Warnings

  • Never combine an ACE inhibitor with an ARB - This increases adverse events (hyperkalemia, syncope, acute kidney injury) without additional cardiovascular benefit 1, 6
  • Monitor serum creatinine and potassium within 7-14 days after initiating or switching ACE inhibitors, particularly in patients with CKD 1, 5
  • An acute rise in serum creatinine up to 30% is acceptable and not a reason to discontinue therapy 5
  • In patients with albuminuria ≥300 mg/g, ACE inhibitors or ARBs are strongly recommended as first-line therapy regardless of blood pressure 1, 5

Combination Therapy Options

If blood pressure remains uncontrolled on benazepril 20mg alone, guideline-recommended additions include:

  • Thiazide-like diuretics (chlorthalidone 12.5-25mg or hydrochlorothiazide 12.5-25mg) 1
  • Dihydropyridine calcium channel blockers (amlodipine 5-10mg) - The ACCOMPLISH trial demonstrated superior cardiovascular and renoprotective outcomes with benazepril/amlodipine combination 7
  • Avoid non-dihydropyridine CCBs (verapamil, diltiazem) in heart failure 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Diabetic Kidney Disease with Elevated Albumin-to-Creatinine Ratio

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hypertension in End-Stage Renal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Renoprotective effects of benazepril: current perspective.

Expert review of cardiovascular therapy, 2011

Guideline

Optimal Antihypertensive Medication Regimen for Patients with Hypertension Urgency, HFrEF, and CAD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.